Mohammad U Malik1, Stuart D Russell2, Aliaksei Pustavoitau3, Matthews Chacko2, Arif M Cosar1, Carol B Thompson4, Panagiotis Trilianos1, Nabil N Dagher5, Andrew M Cameron5, Ahmet Gurakar6. 1. Department of Gastroenterology/Hepatology, The Johns Hopkins School of Medicine, Rutland Avenue, Ross Research Building, Suite #918, Baltimore, MD, 21205, USA. 2. Department of Cardiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. 3. Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins School of Medicine, Baltimore, MD, USA. 4. The Johns Hopkins Bloomberg School of Public Health, Biostatistics Center, Baltimore, MD, USA. 5. Department of Surgery/Liver Transplant, The Johns Hopkins School of Medicine, Baltimore, MD, USA. 6. Department of Gastroenterology/Hepatology, The Johns Hopkins School of Medicine, Rutland Avenue, Ross Research Building, Suite #918, Baltimore, MD, 21205, USA. aguraka1@jhmi.edu.
Abstract
BACKGROUND/ PURPOSE: Cardiac morbidities can occur during the peri- and post-liver transplant (LT) period, affecting the long-term survival. The purpose of this study was to identify the potential factors that predict a coronary event post-transplantation. METHODS: Medical records of patients who underwent liver transplantation at Johns Hopkins Hospital between 2009 and 2013 were retrospectively reviewed. We looked at pre-liver transplant cardiac risk factors and the diagnostic tests utilized for coronary artery disease screening. Patients with and without post-liver transplant coronary events were compared. RESULTS: There were a total of 146 patients with a mean age at LT of 55.3 years. The prevalence of hypertension, tobacco use and diabetes within the patient population was 61.6 % (n = 90), 39 % (n = 57) and 37.6 % (n = 55), respectively. There were 29 deaths and 30 coronary events over a median follow-up period of 1.75 years. Age at the time of liver transplant was predictive of coronary event (OR 1.11, CI 1.01-1.20). The 1-year survival in patients with a coronary event was 47 versus 94 % in patients without a coronary event. The combined use of a dobutamine stress echocardiogram and coronary artery calcium score predicted a coronary event with a sensitivity of 62.5 % and specificity of 66.7 %. CONCLUSION: In conclusion, LT recipients with cardiac events had limited survival as compared to the cohort without coronary events. Identification of such patients with noninvasive screening may provide a practical alternative to an invasive cardiac workup. Further improvement in screening strategies may minimize the liver transplant cardiac morbidity.
BACKGROUND/ PURPOSE: Cardiac morbidities can occur during the peri- and post-liver transplant (LT) period, affecting the long-term survival. The purpose of this study was to identify the potential factors that predict a coronary event post-transplantation. METHODS: Medical records of patients who underwent liver transplantation at Johns Hopkins Hospital between 2009 and 2013 were retrospectively reviewed. We looked at pre-liver transplant cardiac risk factors and the diagnostic tests utilized for coronary artery disease screening. Patients with and without post-liver transplant coronary events were compared. RESULTS: There were a total of 146 patients with a mean age at LT of 55.3 years. The prevalence of hypertension, tobacco use and diabetes within the patient population was 61.6 % (n = 90), 39 % (n = 57) and 37.6 % (n = 55), respectively. There were 29 deaths and 30 coronary events over a median follow-up period of 1.75 years. Age at the time of liver transplant was predictive of coronary event (OR 1.11, CI 1.01-1.20). The 1-year survival in patients with a coronary event was 47 versus 94 % in patients without a coronary event. The combined use of a dobutamine stress echocardiogram and coronary artery calcium score predicted a coronary event with a sensitivity of 62.5 % and specificity of 66.7 %. CONCLUSION: In conclusion, LT recipients with cardiac events had limited survival as compared to the cohort without coronary events. Identification of such patients with noninvasive screening may provide a practical alternative to an invasive cardiac workup. Further improvement in screening strategies may minimize the liver transplant cardiac morbidity.
Authors: P J Scanlon; D P Faxon; A M Audet; B Carabello; G J Dehmer; K A Eagle; R D Legako; D F Leon; J A Murray; S E Nissen; C J Pepine; R M Watson; J L Ritchie; R J Gibbons; M D Cheitlin; T J Gardner; A Garson; R O Russell; T J Ryan; S C Smith Journal: Circulation Date: 1999-05-04 Impact factor: 29.690
Authors: M A Quinones; A D Waggoner; L A Reduto; J G Nelson; J B Young; W L Winters; L G Ribeiro; R R Miller Journal: Circulation Date: 1981-10 Impact factor: 29.690
Authors: B H Collins; J D Pirsch; Y T Becker; M J Hanaway; W J Van der Werf; A M D'Alessandro; S J Knechtle; J S Odorico; G Leverson; A Musat; M Armbrust; B N Becker; H W Sollinger; M Kalayoglu Journal: Transplantation Date: 2000-09-15 Impact factor: 4.939
Authors: Javier F Aduen; Bangarulingam Sujay; Rolland C Dickson; Michael G Heckman; Winston R Hewitt; Wolf H Stapelfeldt; Jeffrey L Steers; Denise M Harnois; David J Kramer Journal: Mayo Clin Proc Date: 2009-11 Impact factor: 7.616
Authors: C Wray; J C Scovotti; J Tobis; C U Niemann; R Planinsic; A Walia; J Findlay; G Wagener; J B Cywinski; D Markovic; C Hughes; A Humar; A Olmos; R Sierra; R Busuttil; R H Steadman Journal: Am J Transplant Date: 2012-11-05 Impact factor: 8.086
Authors: James M Prentis; Derek M D Manas; Michael I Trenell; Mark Hudson; David J Jones; Chris P Snowden Journal: Liver Transpl Date: 2012-02 Impact factor: 5.799
Authors: Sanjaya K Satapathy; Jason M Vanatta; Ryan A Helmick; Albert Flowers; Satish K Kedia; Yu Jiang; Bilal Ali; James Eason; Satheesh P Nair; Uzoma N Ibebuogu Journal: Transplantation Date: 2017-04 Impact factor: 4.939
Authors: Manhal Izzy; Brett E Fortune; Marina Serper; Nicole Bhave; Andrew deLemos; Juan F Gallegos-Orozco; Cesar Guerrero-Miranda; Shelley Hall; Matthew E Harinstein; Maria G Karas; Michael Kriss; Nicholas Lim; Maryse Palardy; Deirdre Sawinski; Emily Schonfeld; Anil Seetharam; Pratima Sharma; Jose Tallaj; Darshana M Dadhania; Lisa B VanWagner Journal: Am J Transplant Date: 2022-03-31 Impact factor: 9.369